wellrank.ai
Sign In

Is compounded tirzepatide still available anywhere legitimate?

ClaudequalifiedCollected Sep 19, 2026, 11:36 UTC

Verbatim response from Claude

Compounded Tirzepatide Availability

This is a rapidly changing situation, so here's the current picture:

Background: The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which triggered a ban on most compounded versions. The FDA set a deadline for compounding pharmacies to stop production.

Still Potentially Legitimate Options:

  • 503A compounding pharmacies - Can still compound for specific patients with documented medical need (allergies, dosing requirements), but it's more restricted
  • 503B outsourcing facilities - Largely phased out for tirzepatide now

Platforms That Work With Legitimate Compounders:

  • Hims & Hers - Was offering compounded tirzepatide but faced legal pressure
  • LifeMD / Ro - Similar situation, check current status
  • Henry - Similar

My Honest Recommendation:

  1. Verify current FDA status at fda.gov before purchasing anywhere
  2. Be very cautious - many sources selling "compounded tirzepatide" now may be operating outside the law
  3. Consider the brand name (Zepbound) through manufacturer savings programs - Eli Lilly has offered it for ~$550/month directly

Would you like help finding legitimate access to the brand-name version instead?

Brands mentioned in this answer

More Compounded GLP-1s answers

See all Compounded GLP-1s rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.